STAT
OCTOBER 17, 2023
When Diana Greene Foster and her team at the University of California, San Francisco, started their study on the lives of women who were denied abortions in 2008, they sought to investigate a rather commonly held view: That having an abortion hurt women’s mental and physical health, including by leading to PTSD and drug and alcohol use disorder.
PharmaVoice
OCTOBER 17, 2023
Phenylephrine’s future is up in the air with an FDA committee saying it’s not effective and a class action lawsuit alleging false advertising. What comes next could have big repercussions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 17, 2023
Lotte Bjerre Knudsen was still getting used to all the empty benches in her lab when she ran into a tall man with black wide-framed glasses in the hallway: Mads Krogsgaard Thomsen, the new head of research at the Danish drugmaker Novo Nordisk, and her new boss. He was just one of many changes she had found upon returning from maternity leave earlier that week — along with the departures of nearly every colleague with whom she had spent the last three years struggling to create a potential
PharmaVoice
OCTOBER 17, 2023
A pharma with a massive collection of rainforest-derived plants needs a regulatory win to overcome last year’s financial decline.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 17, 2023
The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam. Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.
Pharma Times
OCTOBER 17, 2023
The two projects will investigate the potential causes of Parkinson’s disease - News - PharmaTimes
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
OCTOBER 17, 2023
In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert Krystle Buntemeyer, CEO of SCORR Marketing, about the trends and changes for health sciences marketing over the past few years.
STAT
OCTOBER 17, 2023
Are 3D mammograms better than standard 2D imaging for catching advanced cancers? A clinical trial is recruiting thousands of volunteers — including a large number of Black women who face disparities in breast cancer death rates — to try to find out.
Pharmaceutical Technology
OCTOBER 17, 2023
In October 2023, Novo Nordisk announced that its trial studying Ozempic (semaglutide) in diabetic CKD patients, will come to a halt almost a year prior to its planned completion.
STAT
OCTOBER 17, 2023
E ach year, STAT sets out to celebrate the unheralded heroes of science and medicine, poring over hundreds of nominations from across North America in search for the next generation of scientific superstars. This year’s class of 28 Wunderkinds were selected from more than 170 brilliant researchers. In this video, we chat with Ahmed Ahmed, who studies the impact of unionization on health care workers; Josh Tycko, who’s focused on epigenetic editing; Kristine Chua, who studies how bi
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
OCTOBER 17, 2023
In final guidance , the National Institute for Health and Care Excellence (NICE) has recommended glofitamab as a new treatment option for advanced lymphoma. NICE’s recommendation coincides with the Medicines and Healthcare Products Regulatory Agency (MHRA) granting a licence for glofitamab” The bispecific monoclonal antibody (BsAb) treatment is indicated for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more systemic treatments.
STAT
OCTOBER 17, 2023
WASHINGTON — Doctors lowered the incidence of heart disease and strokes among their patients when Medicare rewarded them for focusing on sicker patients, according to research of a pilot program released Tuesday in the Journal of the American Medical Association. The pilot program didn’t increase overall costs at all. The five-year pilot program is one of many that Medicare has run since the Affordable Care Act created an office to test whether Medicare payment policies can influen
BioPharma Dive
OCTOBER 17, 2023
Nucleus RadioPharma, a contract developer and manufacturer, is expanding at a time when investment is pouring into the radiopharmaceutical drug field.
STAT
OCTOBER 17, 2023
Revenue cycle management company Waystar filed for an initial public offering Monday with the Securities and Exchange Commission. The company did not specify how many shares it plans to offer or what share price it is targeting. Previous reports have pegged the company’s potential valuation at $8 billion, which would make it larger than competitor R1 RCM, which is valued at a $5.5 billion market cap.
European Pharmaceutical Review
OCTOBER 17, 2023
The US Food and Drug Administration (FDA) has published draft guidance on how it intends to use alternative tools for assessing drug manufacturing facilities identified in pending marketing applications. For example, the applications are New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), or a Biologics License Applications (BLAs).
STAT
OCTOBER 17, 2023
Rise and shine, everyone, another busy day is on the way. We can tell, in part, because the official mascots are racing about the grounds at top speed and the number of cars and trucks passing outside our window is picking up. But this is to be expected, yes? So as we collect our thoughts about the day ahead, we are firing up the coffee kettle for another cup of stimulation.
PioneerRx
OCTOBER 17, 2023
As you might have heard, there’s been a slight change of plans in the world of DSCSA compliance. On August 30, the FDA announced a “1-year stabilization period.
STAT
OCTOBER 17, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the latest twist in the GLP-1 saga, some drama in the world of Covid-19 booster shots, and the debut of the 2023 STAT Wunderkinds.
Express Pharma
OCTOBER 17, 2023
Cellipoint Bioservices entered an agreement with Diakonos Oncology in October 2023 for the development and manufacturing of DOC1021, an autologous dendritic cell (DC) vaccine. The collaboration was announced after Diakonos Oncology revealed promising results of the ongoing Phase I trial evaluating DOC1021 in newly diagnosed patients with glioblastoma multiforme (GBM) administered following surgical intervention and standard postoperative chemoradiation.
Pharmaceutical Technology
OCTOBER 17, 2023
As AI applications in drug manufacturing widen, Leucine’s digital twin of the shop floor helps automate compliance and improve safety.
Pharma Times
OCTOBER 17, 2023
The condition is responsible for 2,200 annual deaths in the UK - News - PharmaTimes
PharmaTech
OCTOBER 17, 2023
Chris Spivey, editorial director, hosts a wide ranging discussion on the COVID-19 pandemic response, future government communications, and healthcare funding for mRNA with experts Dr. Kate Broderick, Chief Innovation Officer, Maravai LifeSciences and Dr. Tom Madden, President & CEO at Acuitas Therapeutics. Highlights include supply chain modalities, ensuring a fully trained manufacturing workforce, combining delivery with gene editing innovations, epigenetic approaches to modulate gene expre
Express Pharma
OCTOBER 17, 2023
Praxair India (a Linde company) announced the commencement of commercial production at its air separation unit (ASU) at Patancheru in Hyderabad, Telangana on October 14, 2023. This plant will be producing in total 250 tonnes per day of gases including liquid medical oxygen, nitrogen and argon, catering to the requirements of healthcare, pharma and other industrial sectors of the region.
Outsourcing Pharma
OCTOBER 17, 2023
AstraZenecaâs supplemental new drug application (sNDA) for lead lung cancer drug Tagrisso (Osimertinib) in combination with chemotherapy has been accepted and granted priority review in the US.
Pharmaceutical Technology
OCTOBER 17, 2023
SpliceBio will license Spark Therapeutics’ propriety protein splicing platform to develop a gene therapy for renal disease.
World Pharma News
OCTOBER 17, 2023
A technique developed by University of Texas at Dallas and UT Southwestern Medical Center researchers to deliver medication through the blood-brain barrier has shown promise in a preclinical study for treating glioblastoma, the most common human brain cancer. The researchers demonstrated the method in mice in a study published online Aug. 15 in Nature Communications.
BioPharma Dive
OCTOBER 17, 2023
The Danish drugmaker's innovation hub in Boston has teamed up with the Broad Institute, Mass General Brigham, Harvard and Yale, expanding its research into cardiometabolic diseases.
Outsourcing Pharma
OCTOBER 17, 2023
Saama, a provider of artificial intelligence (AI) based solutions, announced today (October 17) that it has formed a multi-year agreement with biopharma giant, AstraZeneca.
PharmExec
OCTOBER 17, 2023
Morton discusses his transition from working as a urologist to the C-suite.
pharmaphorum
OCTOBER 17, 2023
Roche builds gene therapy portfolio with SpliceBio deal Phil.
BioPharma Dive
OCTOBER 17, 2023
One month after Roche’s Genentech inked a similar deal, the Swiss pharma is now paying $50 million to work with Monte Rosa on molecular glue medicines for cancer and neurological diseases.
pharmaphorum
OCTOBER 17, 2023
Owkin signs up another pharma partner for its AI platform Phil.
Putting Patients First Blog
OCTOBER 17, 2023
Weight Management and Health for People Living with Chronic Conditions 10/17/2023 Weight Management and Health for People Living with Chronic Conditions (PDF) Executive Summary Obesity is one of the most critical nutritional diseases in today’s world. While research behind obesity intervention have, for the past few decades, circumnavigated topics like diet and workout programs, modern medicine has proven that medical interventions, in conjunction with diet and exercise, can drastically ai
pharmaphorum
OCTOBER 17, 2023
VR-based navigation test may detect Alzheimer’s Phil.
Putting Patients First Blog
OCTOBER 17, 2023
Guest Post: In Celebration of National Pharmacy Month October 17, 2023 By Susan Cantrell, CEO of the Academy of Managed Care Pharmacy With October devoted to National Pharmacy Awareness, I wanted to take this opportunity to talk about the outstanding efforts of managed care pharmacists across the United States. As CEO of the Academy of Managed Care Pharmacy (AMCP), I frequently see and hear about these activities — how so many in the world of managed care pharmacy consistently strive to impro
Expert insights. Personalized for you.
354 
Let's personalize your content